Gansu Longshenrongfa Pharmaceutical Industry Co Ltd300534
▲ ポジティブ規制関連度
State Council approval of TCM 15th Five-Year Plan directly benefits Longshen Rongfa as a TCM company, driving its 20% limit-up.
銘柄への影響 7
その他
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
Shan Dong Dong-E E-Jiao Co Ltd000423
▲ ポジティブ需要関連度
Dong-E-E-Jiao mentioned by analyst as a high-dividend TCM firm with allocation appeal in low-rate environment.
Hubei Jumpcan Pharmaceutical Co Ltd600566
▲ ポジティブ需要関連度
State Council approval of TCM 15th Five-Year Plan boosts sector demand; analyst notes high-dividend TCM firms like Jumpcan have allocation appeal.
Jiangzhong Pharmaceutical Co Ltd600750
▲ ポジティブ需要関連度
China Resources Jiangzhong mentioned by analyst as a high-dividend TCM firm with allocation appeal in low-rate environment.
Shanghai Kaibao Pharmaceutical300039
▲ ポジティブ需要関連度
Shanghai Kaibao surged over 10% on sector rally driven by State Council plan approval.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd600671
▲ ポジティブ需要関連度
Tianmu Pharmaceutical hit daily limit up on sector-wide rally driven by State Council plan approval.
Zhejiang Xinguang Pharmaceutical Co Ltd300519
言及
テーマインパクト
カバレッジ外企業 1
云南生物谷药业股份有限公司 (Yunnan Biovalley Pharmaceutical Co., Ltd.)非上場▲ ポジティブ
規制関連度
State Council approval of TCM 15th Five-Year Plan boosts Biotech Valley, a TCM firm, leading to over 10% surge.